Supply Chain

The Food and Drug Administration recently rejected Dynavax Technology Corp.'s hepatitis B drug, Heplisav-B, for the second time in three years, reports Reuters.

The Food and Drug Administration recently granted priority review status to Novartis' experimental leukemia drug midostaurin, reports Reuters.

The Cubs' World Series win last week conveniently allowed sporting apparel retailer Fanatics to practice managing higher-than-normal consumer demands before the holiday season's expected surge in orders, reports The Wall Street Journal.

 United Postal Service will build a $400 million regional package sorting facility in Atlanta, reports DC Velocity.

The Food and Drug Administration recently approved Vemlidy, a once-daily treatment for patients with compensated liver disease caused by chronic hepatitis B virus.

Trucking companies are optimistic President-elect Donald Trump will boost road spending and address a controversial safety regulation set to take effect next year, reports The Wall Street Journal.

As the healthcare industry moves from a fee-for-service model to value-based care, controlling spend on high-value supplies is more critical than ever. The use of automation and data analytics allows supply chain leaders to transform data into actionable insights that…

The Food and Drug Administration cemented a final rule Tuesday updating regulations to its citizen petitions. reports the Regulatory Affairs Professionals Society.

Bristol-Myers Squibb paid $100 million upfront for the rights to Japanese drugmaker Nitto Denko's experimental fibrosis drug, reports Reuters.

A recent decision by the Food and Drug Administration will allow Keryx Biopharmaceuticals to overcome a large obstacle in the manufacturing of its kidney drug Auryxia, according to the Boston Business Journal.